(Q42256548)

19 October 2017

Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies (English)

1 reference

19 October 2017

1 reference

Fausti SA

1

1 reference

19 October 2017

Rappaport BZ

2

1 reference

19 October 2017

Schechter MA

3

1 reference

19 October 2017

Frey RH

4

1 reference

19 October 2017

Ward TT

5

1 reference

19 October 2017

Brummett RE

6

1 reference

19 October 2017

1 May 1984

1 reference

American Journal of Otolaryngology

19 October 2017

1 reference

19 October 2017

5

1 reference

19 October 2017

3

1 reference

19 October 2017

177-182

1 reference

Ototoxicity of Gentamicin in Man: A Survey and Controlled Analysis of Clinical Experience in the United States

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0709%2884%2980009-5

7 January 2021

Aminoglycoside ototoxicity in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0709%2884%2980009-5

7 January 2021

Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0709%2884%2980009-5

7 January 2021

Immediate effects of tobramycin on human cochlea and correlation with serum tobramycin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0709%2884%2980009-5

7 January 2021

Why Monitor Serum Levels of Gentamicin?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0709%2884%2980009-5

7 January 2021

Ototoxic hearing loss and cochlear pathology in the monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0709%2884%2980009-5

7 January 2021

A system for evaluating auditory function from 8000–20 000 Hz

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0709%2884%2980009-5

7 January 2021

10.1016/S0196-0709(84)80009-5

Identifiers

DOI

1 reference

19 October 2017

1 reference